Bioventus Acquisition Pays Off in Third Quarter

Bioventus reported 3Q21 orthopedic sales of $108.9 million, +26.8% vs. 3Q20. Recently acquired Bioness contributed $11 million in sales, accounting for nearly half of the company's growth in the quarter. The company increased its full-year 2021 guidance to the range of $425 million to $430 million to reflect two full months of sales from...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us